首页> 外文期刊>Bone marrow transplantation >Sputum cytokine levels in patients undergoing hematopoietic SCT and comparison with healthy subjects and COPD: A pilot study
【24h】

Sputum cytokine levels in patients undergoing hematopoietic SCT and comparison with healthy subjects and COPD: A pilot study

机译:经过造血SCT的患者的痰细胞因子水平,与健康受试者和COPD比较:试点研究

获取原文
获取原文并翻译 | 示例
       

摘要

Patients undergoing hematopoietic SCT (HSCT) display an airway neutrophilic inflammation before transplantation that persists over the years. In this study, we have investigated the cytokine profile over a period of 1 year in the sputum supernatant of patients who underwent HSCT. We have measured sputum supernatant levels of TNF-α, TGF-β1, IL-4, IL-5, IL-6, IL-8, IL-10, IL-13, IL-17 and IFN-γ in 49 HSCT patients and compared the results with those found in 40 chronic obstructive pulmonary disease (COPD) and 54 healthy subjects matched for age. Compared with healthy subjects, before transplantation, HSCT patients exhibited raised levels of IL-6 (P<0.001) and IL-8 (P<0.05) while the other cytokines were generally poorly detectable. This picture was rather similar to that seen in COPD even if cytokine levels were much greater in the latter, with IL-8 being significantly greater in COPD than in HSCT patients (P<0.0001). In the 1 year following transplantation, sputum IL-6 and IL-8 did not differ from those in healthy subjects. Overall in HSCT patients, sputum IL-8 and IL-6 correlated with sputum neutrophil counts (r=0.4, P<0.0001; r=0.42, P<0.0001, respectively). In conclusion, sputum IL-6 and IL-8 may play a role in neutrophilic airway inflammation seen in patients undergoing HSCT.
机译:经过造血SCT(HSCT)的患者在移植前展示持续多年来的气道中性粒乳炎症。在这项研究中,我们研究了在接受HSCT的患者的痰上清液中的1年内进行了细胞因子概况。我们在49个HSCT患者中测量了TNF-α,TGF-β1,IL-4,IL-5,IL-13,IL-17和IFN-γ的痰上清液水平的TNF-α,TGF-β1,IL-4,IL-10,IL-13,IL-17和IFN-γ并将结果与​​40名慢性阻塞性肺病(COPD)和54名健康受试者进行比较。与健康受试者相比,移植前,HSCT患者表现出升级的IL-6(P <0.001)和IL-8(P <0.05),而其他细胞因子通常可检测到差。这张照片与COPD中看到的那些相似,即使在后者中细胞因子水平要大得多,IL-8在COPD中显着大于HSCT患者(P <0.0001)。在移植后的1年内,痰IL-6和IL-8与健康受试者的含量没有差异。总体而言,在HSCT患者中,痰IL-8和IL-6与痰中性粒细胞计数相关(r = 0.4,p <0.0001; r = 0.42,p <0.0001)。总之,痰IL-6和IL-8可能在接受HSCT患者中看到的中性粒细胞气道炎症作用。

著录项

  • 来源
    《Bone marrow transplantation》 |2014年第11期|共7页
  • 作者单位

    Department of Pneumology-Allergology CHU of Liege University of Liege Avenue de l'hopitalLiege;

    Department of Hematology-Oncology CHU of Liege University of LiegeLiege Belgium;

    Department of Hematology-Oncology CHU of Liege University of LiegeLiege Belgium;

    Department of Hematology-Oncology CHU of Liege University of LiegeLiege Belgium;

    Department of Pneumology-Allergology CHU of Liege University of Liege Avenue de l'hopitalLiege;

    Department of Pneumology-Allergology CHU of Liege University of Liege Avenue de l'hopitalLiege;

    Department of Pneumology-Allergology CHU of Liege University of Liege Avenue de l'hopitalLiege;

    Department of Pneumology-Allergology CHU of Liege University of Liege Avenue de l'hopitalLiege;

    Department of Hematology-Oncology CHU of Liege University of LiegeLiege Belgium;

    Department of Pneumology-Allergology CHU of Liege University of Liege Avenue de l'hopitalLiege;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 治疗学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号